TA
Protara Therapeutics, Inc.
TARA · NASDAQ
$3.68 +3.81% (+$0.14)
1M -9.30%
Market Cap $206.8M
P/E Ratio -
Div. Yield -
ROE 41.72%
Bulios Fair Price
$2.27
38.3% downside
Trenutna cena
$3.68
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TARA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 1.28x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 24.38%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 46.81%
ROE 41.72%
ROA 39.76%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 10.97x
Int. coverage N/A
Stability
56 /100
Moderate Beta 1.49x
EPS volatility 0.52%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TARA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jesse Shefferman
Employees
46
Headquarters
New York City
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report